The Latest

• August 30, 2020

  By Artie Villasanta

  Remdesivir Use Expanded To Include Patients With Suspected COVID-19

  The U.S. Food and Drug Administration, now, allows remdesivir (brand name, Veklury) to be used for the treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19.

  

  The U.S. Food and Drug Administration, now, allows remdesivir (brand name, Veklury) to be used for the treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19.